Inhibiting AChE prevents it from lysing the neurotransmitter, acetylcholine, thus, allowing the increase of acetylcholine levels in neuromuscular junctions in the brain to occur, thereby, helping to prevent the loss of the cholinergic neurons' function that is experienced in AD patients [33]. Here, ACHE is linked to Alzheimer disease.